- Home
- SRZN vs PDEX Comparison
SRZN vs PDEX Comparison
Compare SRZN & PDEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRZN
- PDEX
- Stock Information
- Founded
- SRZN 2015
- PDEX 1978
- Country
- SRZN United States
- PDEX United States
- Employees
- SRZN N/A
- PDEX N/A
- Industry
- SRZN Medicinal Chemicals and Botanical Products
- PDEX Medical/Dental Instruments
- Sector
- SRZN Health Care
- PDEX Health Care
- Exchange
- SRZN Nasdaq
- PDEX Nasdaq
- Market Cap
- SRZN 97.3M
- PDEX 85.5M
- IPO Year
- SRZN N/A
- PDEX N/A
- Fundamental
- Price
- SRZN $13.73
- PDEX $28.71
- Analyst Decision
- SRZN Strong Buy
- PDEX Strong Buy
- Analyst Count
- SRZN 2
- PDEX 1
- Target Price
- SRZN $38.50
- PDEX $56.00
- AVG Volume (30 Days)
- SRZN 22.2K
- PDEX 79.2K
- Earning Date
- SRZN 11-07-2025
- PDEX 10-31-2025
- Dividend Yield
- SRZN N/A
- PDEX N/A
- EPS Growth
- SRZN N/A
- PDEX 345.00
- EPS
- SRZN N/A
- PDEX 2.67
- Revenue
- SRZN $12,621,000.00
- PDEX $66,593,000.00
- Revenue This Year
- SRZN N/A
- PDEX $7.22
- Revenue Next Year
- SRZN N/A
- PDEX N/A
- P/E Ratio
- SRZN N/A
- PDEX $10.85
- Revenue Growth
- SRZN N/A
- PDEX 23.68
- 52 Week Low
- SRZN $5.90
- PDEX $23.47
- 52 Week High
- SRZN $18.17
- PDEX $70.26
- Technical
- Relative Strength Index (RSI)
- SRZN 59.16
- PDEX 43.01
- Support Level
- SRZN $13.55
- PDEX $23.52
- Resistance Level
- SRZN $13.94
- PDEX $29.30
- Average True Range (ATR)
- SRZN 0.33
- PDEX 2.30
- MACD
- SRZN -0.08
- PDEX 0.47
- Stochastic Oscillator
- SRZN 46.94
- PDEX 43.35
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).
About PDEX Pro-Dex Inc.
Pro-Dex Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers (OEMs) to various countries. Its product portfolio includes autoclavable, battery-powered, electric, and multi-function surgical drivers and shavers used mainly in orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, regulatory consulting services, and manufactures rotary air motors utilized in various industries. Operating out of ISO-certified facilities in California, Pro-Dex serves hospitals, medical labs, and high-tech manufacturers, generating revenue through sales of surgical instruments and related services.